Vishwas Seshadri - 29 Sep 2025 Form 4 Insider Report for ABEONA THERAPEUTICS INC. (ABEO)

Role
Chief Executive Officer, Director
Signature
/s/ Vishwas Seshadri
Issuer symbol
ABEO
Transactions as of
29 Sep 2025
Net transactions value
-$234,884
Form type
4
Filing time
01 Oct 2025, 16:30:11 UTC
Previous filing
10 Jul 2025
Next filing
16 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Seshadri Vishwas Chief Executive Officer, Director 6555 CARNEGIE AVE., 4TH FLOOR, CLEVELAND /s/ Vishwas Seshadri 01 Oct 2025 0001865131

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABEO Common Stock Sale $103,954 -19,274 -1.6% $5.39 1,215,067 29 Sep 2025 Direct F1, F2
transaction ABEO Common Stock Sale $130,930 -25,000 -2.1% $5.24 1,190,067 30 Sep 2025 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.35 to $5.46 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 The reported sale of 25,000 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.20 to $5.2725 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.